Zacks Investment Research on MSN
PCRX, LG Chem partner to expand Exparel reach across the Asia-Pacific
Pacira BioSciences PCRX announced a partnership with LG Chem to broaden access to opioid-sparing postsurgical pain management ...
Exparel (bupivacaine liposomal) is a brand-name drug prescribed for pain relief after surgery in adults and some children. Exparel comes as an injection that’s given as a single dose by a healthcare ...
Doctors prescribe Exparel (bupivacaine liposome injectable suspension) for pain relief after surgery. The drug’s cost may depend on your dosage and whether you have health insurance. It may also ...
Please provide your email address to receive an email when new articles are posted on . Postoperative pain is the No. 1 complaint among our surgical patients, especially among those undergoing corneal ...
According to the American College of Surgeons, 15 million Americans undergo surgery each year. Despite this high frequency and the significant impact these procedures can have on patients, no ...
-- Advances global expansion strategy to minimize postsurgical opioid use worldwide -- PARSIPPANY, N.J., June 25, 2019 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (“Pacira”) (NASDAQ: PCRX) today ...
TAMPA, Fla., March 15, 2022 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today ...
Exparel (bupivacaine liposome injectable suspension) is prescribed for pain relief after surgery. The drug comes as a suspension. A healthcare professional injects this type of liquid mixture as a one ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback